Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting, 73286 [2020-25335]
Download as PDF
73286
Federal Register / Vol. 85, No. 222 / Tuesday, November 17, 2020 / Notices
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel Preclinical and Translational
Vaccine Development Support for HIV and
Other Candidate Agents (PTVDS) (N01), Task
Areas E and F.
Date: December 9–10, 2020.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G31,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: Cynthia L. De La Fuente,
Ph.D., Scientific Review Officer, Scientific
Review Program, National Institute of Allergy
and Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G31,
Rockville, MD 20852, 240–669–2740,
delafuentecl@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Rehabilitation Research Funding; Discussion
of Lessons Learned from the Pandemic
(supporting research activities and the needs
of people with disabilities); Agenda Planning
for the next Board meeting.
Place: National Institutes of Health, Eunice
Kennedy Shriver National Institute of Child
Health and Human Development, National
Institutes of Health, 6710B Rockledge Drive,
Bethesda, MD 20892–7510 (Virtual Meeting).
Contact Person: Ralph M. Nitkin, Ph.D.,
Director, Biological Sciences and Career
Development Program, National Center for
Medical Rehabilitation Research, Eunice
Kennedy Shriver National Institute of Child
Health and Human Development, National
Institutes of Health, 6710B Rockledge Drive,
Room 2116, Bethesda, MD 20892–7510, (301)
402–4206, nitkinr@mail.nih.gov.
The meeting will be NIH Videocast. Please
select the following link for Videocast on the
day of the meeting: https://videocast.nih.gov/
default.asp.
Information is also available on the
Institute’s/Center’s home page: https://
www.nichd.nih.gov/about/advisory/nabmrr/
Pages/index.aspx where the current roster
and minutes from past meetings are posted.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: November 10, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: November 12, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–25284 Filed 11–16–20; 8:45 am]
[FR Doc. 2020–25335 Filed 11–16–20; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Meeting
National Cancer Institute; Notice of
Closed Meetings
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory Board
on Medical Rehabilitation Research.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Advisory
Board on Medical Rehabilitation Research.
Date: December 7, 2020.
Time: 10:00 a.m. to 2:30 p.m.
Agenda: NICHD Director’s report; NCMRR
Director’s report; Updates on the NIH
Rehabilitation Research Conference and NIH
VerDate Sep<11>2014
19:46 Nov 16, 2020
Jkt 253001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Tobacco
Use and HIV in Low- and Middle-Income
Countries.
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Date: January 13, 2021.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W108, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Clifford W. Schweinfest,
Ph.D., Scientific Review Officer, Special
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W108,
Rockville, MD 20850, 240–276–6343,
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI SPORE
(P50) Review I.
Date: January 26–27, 2021.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W244, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: John Paul Cairns, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, 9609 Medical Center Drive, Room
7W244, National Cancer Institute, NIH,
Rockville, MD 20850, 240–276–5415,
paul.cairns@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI SPORE
(P50) Review II.
Date: January 27–28, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W116, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Klaus B. Piontek, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W116,
Rockville, MD 20850, 240–276–5413,
klaus.piontek@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI SPORE
(P50) Review III.
Date: January 28–29, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, 7W122,
Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Anita T. Tandle, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W122,
Rockville, MD 20850, 240–276–5085,
tandlea@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Innovative
Molecular and Cellular Analysis
Technologies.
Date: February 4–5, 2021.
Time: 11:00 a.m. to 6:00 p.m.
E:\FR\FM\17NON1.SGM
17NON1
Agencies
[Federal Register Volume 85, Number 222 (Tuesday, November 17, 2020)]
[Notices]
[Page 73286]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-25335]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human
Development; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Board on Medical Rehabilitation Research.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: National Advisory Board on Medical
Rehabilitation Research.
Date: December 7, 2020.
Time: 10:00 a.m. to 2:30 p.m.
Agenda: NICHD Director's report; NCMRR Director's report;
Updates on the NIH Rehabilitation Research Conference and NIH
Rehabilitation Research Funding; Discussion of Lessons Learned from
the Pandemic (supporting research activities and the needs of people
with disabilities); Agenda Planning for the next Board meeting.
Place: National Institutes of Health, Eunice Kennedy Shriver
National Institute of Child Health and Human Development, National
Institutes of Health, 6710B Rockledge Drive, Bethesda, MD 20892-7510
(Virtual Meeting).
Contact Person: Ralph M. Nitkin, Ph.D., Director, Biological
Sciences and Career Development Program, National Center for Medical
Rehabilitation Research, Eunice Kennedy Shriver National Institute
of Child Health and Human Development, National Institutes of
Health, 6710B Rockledge Drive, Room 2116, Bethesda, MD 20892-7510,
(301) 402-4206, [email protected].
The meeting will be NIH Videocast. Please select the following
link for Videocast on the day of the meeting: https://videocast.nih.gov/default.asp.
Information is also available on the Institute's/Center's home
page: https://www.nichd.nih.gov/about/advisory/nabmrr/Pages/index.aspx where the current roster and minutes from past meetings
are posted.
(Catalogue of Federal Domestic Assistance Program Nos. 93.864,
Population Research; 93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation Research; 93.209,
Contraception and Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: November 12, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-25335 Filed 11-16-20; 8:45 am]
BILLING CODE 4140-01-P